AMH Test (Anti-Müllerian Hormone) in Kingston

AMH (Anti-Müllerian Hormone) is produced by small follicles in the ovaries. The blood level reflects the size of your remaining ovarian reserve - the pool of eggs available for future ovulation. Every AMH result is reviewed by a GMC-registered doctor. You will receive one of two outcomes: either no action is needed and the result is reassuring, or the doctor recommends a follow-up GP consultation - either with your NHS GP, or with a KONCEPT® GP (£149 consultation fee).

Women planning to conceive, women considering egg freezing, women in perimenopause and menopause wanting to understand their ovarian reserve, women diagnosed or being investigated for PCOS (AMH is often elevated in PCOS), and women on long-term hormonal contraception wanting a baseline fertility insight.

Most results are returned within 2 to 5 working days. If a specific test takes longer, you will be informed in advance.

No. You can book online, in person at the clinic, or add the AMH test during a GP consultation at KONCEPT®.

AMH is relatively stable across the menstrual cycle, so the blood draw can be taken on any day. This is unlike FSH and LH, which need to be drawn on day 2 to 5 of the cycle.

No fasting required. Stay well hydrated. If you take biotin supplements, stop 48 to 72 hours before the test as biotin interferes with several lab assays including AMH. Hormonal contraception (combined pill, mini-pill, hormonal coil, implant) can mildly suppress AMH results - mention this when booking so the doctor can interpret your result correctly.

All tests are reviewed before and after the test by one of our GMC-registered doctors. A short outcome note with a next-step plan is sent to your email, password-protected. If results are normal, no further action is needed. If anything requires attention, the doctor will recommend a follow-up GP consultation - either with your NHS GP or with one of our GPs at KONCEPT® (a £149 consultation fee applies if you choose KONCEPT®).

A single administration fee charged once per visit, never per test, regardless of how many tests are in the basket. The all-in AMH price of £148 already includes it.

Only with your written consent. We can send a clinical summary to your NHS GP for coordinated long-term care, including any future fertility referrals.

46 to 48 Wood Street, Kingston upon Thames, KT1 1UW. KONCEPT® Medical Clinic is located opposite Kingston station. Parking nearby at the Bentall Centre.

At KONCEPT® Medical Clinic in Kingston, an AMH test costs £148 all-in (£109 test fee plus a single £39 administration fee charged once per visit, never per test). The all-in price includes the venous blood draw at the clinic, processing by an accredited UK pathology laboratory, doctor review of the result, and a short outcome note sent securely by password-protected email. If a GP review is recommended, that is a separate booking: your NHS GP at no NHS charge, or a KONCEPT® GP consultation at £149 (Tier 2 above).

AMH is not routinely tested in NHS primary care. Under NICE NG73 (Fertility problems: assessment and treatment), AMH is recommended in specific NHS fertility-clinic contexts (for example, IVF assessment) where local commissioning criteria apply. Women who want an AMH check for fertility planning, egg-freezing assessment or perimenopause review often cannot access it through their NHS GP without meeting fertility-clinic eligibility criteria. KONCEPT® offers AMH directly, without referral, alongside your NHS care. With your written consent we share a clinical summary with your NHS GP so the result is added to your NHS record.

AMH is interpreted against age-banded reference ranges. The exact ranges vary between laboratories and assays, but the broad pattern is consistent: AMH typically declines with age, reflecting the natural decline in ovarian reserve over time. The table above shows the indicative bands used by many UK laboratories. Your individual report will state the specific reference range used by the laboratory that processed your sample. A number outside the expected band is not in itself a diagnosis and is interpreted by a GMC-registered doctor against your full clinical context. AMH does not predict the chance of conception, IVF success, or the time until menopause.

An AMH result lower than the expected range for your age reflects reduced ovarian reserve, meaning a smaller pool of remaining follicles than is typical for the age band. It is a measure of follicle quantity, not egg quality, and does not predict your chance of conception or IVF success. Many women with lower-than-expected AMH conceive naturally. The doctor interprets the result against your age, cycle history, contraception use, recent fertility treatment and other clinical factors, and recommends the appropriate next step. This may be a more comprehensive panel such as our Women's Amenorrhoea & Fertility Blood Test, a GP consultation, or onward fertility specialist referral.

Higher-than-expected AMH for the age band is often seen in polycystic ovary syndrome (PCOS), where the larger pool of small follicles characteristic of polycystic ovaries produces more AMH. AMH is one input the doctor uses when considering a PCOS diagnosis alongside the Rotterdam criteria (symptoms, cycle pattern, examination findings, and other markers including LH, FSH, SHBG, testosterone and ultrasound). If a high AMH suggests further investigation, the doctor may recommend the PCOS Blood Test (14 markers) or a Wellwomen-led pathway.

AMH is one input fertility specialists consider when discussing egg-freezing options, alongside age, ovarian volume, antral follicle count on ultrasound, and the patient's wider clinical history. AMH does not predict the number of eggs that will be successfully frozen or future egg quality. A KONCEPT® AMH test gives you a doctor-reviewed ovarian-reserve marker to take into a private fertility specialist consultation. The egg-freezing decision and procedure are not provided at KONCEPT® and require referral to a CQC-registered fertility clinic.

AMH declines with age and is generally low in perimenopause and undetectable in menopause, reflecting the natural reduction in ovarian reserve. AMH on its own does not diagnose perimenopause or predict the time until menopause. For perimenopausal women wanting a broader hormonal review, the Perimenopause & Menopause Foundation panel (8 markers including FSH, LH, oestradiol, prolactin and thyroid) is the more useful test, with AMH available as an additional marker if appropriate.

Online home-kit packages can measure AMH from a finger-prick sample because the assay tolerates small volumes. The differentiator is interpretation and what happens next. Home kits return an algorithm-generated PDF with an age-banded comparison, and the patient then decides what to do. At KONCEPT® a GMC-registered doctor reviews the request before the test (checking for biotin, hormonal contraception and other factors that affect interpretation), reviews the result against the laboratory's reference range and your clinical context, and sends a short outcome note stating either that the result is within expected range or that a GP review is recommended. See the comparison table above for the full side-by-side.

AMH is not routinely tested in NHS primary care. The NHS pathway provides AMH within fertility-clinic contexts where eligibility criteria apply (NICE NG73). KONCEPT® offers AMH directly without referral, with doctor-reviewed interpretation against age-banded ranges and your clinical context. With your written consent we share a clinical summary with your NHS GP so the result is added to your NHS record alongside your ongoing care.